Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer.

Autor: Dovšak T; Clinical Department of Maxillofacial and Oral Surgery, |University Medical Center, Ljubljana, Slovenia. tadej.dovsak@gmail.com.; Department of Maxillofacial and Oral Surgery, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1104, Ljubljana, Slovenia. tadej.dovsak@gmail.com., Ihan A; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Didanovič V; Clinical Department of Maxillofacial and Oral Surgery, |University Medical Center, Ljubljana, Slovenia.; Department of Maxillofacial and Oral Surgery, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1104, Ljubljana, Slovenia., Kansky A; Clinical Department of Maxillofacial and Oral Surgery, |University Medical Center, Ljubljana, Slovenia.; Department of Maxillofacial and Oral Surgery, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1104, Ljubljana, Slovenia., Verdenik M; Clinical Department of Maxillofacial and Oral Surgery, |University Medical Center, Ljubljana, Slovenia.; Department of Maxillofacial and Oral Surgery, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1104, Ljubljana, Slovenia., Hren NI; Clinical Department of Maxillofacial and Oral Surgery, |University Medical Center, Ljubljana, Slovenia.; Department of Maxillofacial and Oral Surgery, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1104, Ljubljana, Slovenia.
Jazyk: angličtina
Zdroj: BMC cancer [BMC Cancer] 2018 Mar 01; Vol. 18 (1), pp. 235. Date of Electronic Publication: 2018 Mar 01.
DOI: 10.1186/s12885-018-4136-9
Abstrakt: Background: The immune system has a known role in the aetiology, progression and final treatment outcome of oral squamous cell cancers. The aim of this study was to evaluate the influence of radical surgery and radiotherapy on advanced oral squamous cell carcinoma blood counts, lymphocyte subsets and levels of acute inflammatory response markers.
Methods: Blood samples were obtained from 56 patients 5 days before and 10 days after surgery, 30 days and 1 year after radiotherapy. The whole blood count, lymphocyte subsets and inflammatory response markers (C-reactive protein, erythrocyte sedimentation rate, leukocyte count, expression of index CD64 and index CD163 on neutrophils and monocytes) were measured, statistically analysed and correlated with clinical treatment outcomes.
Results: The post-operative period was characterised by the onset of anaemia, thrombocytosis, lymphopenia with reduced B lymphocyte, T helper cell and NK cell counts, and a rise in acute phase reactants. Immediately after radiotherapy, the anaemia improved, the lymphopenia worsened, and thrombocyte levels returned to pre-treatment values. There was a drop in counts across the T and B cell lines, including a reduction in B lymphocytes, naïve and memory T cells with reduced CD4+ and CD8+ counts and a decreased CD4/CD8 ratio. One year after radiotherapy all the lymphocyte subsets remained depressed, the only exception being NK cells, whose levels returned to pre-treatment values.
Conclusions: We concluded that surgery resulted in a stronger acute phase response than radiotherapy, while radiotherapy caused a long-lasting reduction in lymphocyte counts. There was no correlation between any of the pre-treatment parameters and the clinical outcome.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje